How to implement and perform effective Due Diligence?
3 experts already confirmed their presence in this thrilling session!
Scheduled December 2nd at 2pm, the session will raise crucial questions going with the Due Diligence process. Due diligence is a complex analysis of the commercial, legal and financial data that needs to be well prepared, how can a biotech company best prepare for this process? How long does the process last? What are the expectations on pharma’s side?
To answer these questions, 3 top-notch speakers already confirmed their presence:
- Cécile Théard-Jallu, partner at De Gaulle Fleurance et Associés, will speak alongside
- Martin Cadman, scientific Licensing Director at GlaxoSmithKline and
- Carl Jessop, Due Diligence Director at AstraZeneca to address this complex topic!
We are already looking forward to attending this promising session!
Want to speak at BioFIT? Contact Ramona Pirv-Chicireanu, Conference Coordinator
